Auxly Cannabis Group Inc (CBWTF)
OTHER OTC:CBWTF
Want to see CBWTF full AI Analyst Report?
CBWTF Stock Chart & Stats
$0.11
>-$0.01(-3.94%)
At close: 4:00 PM EST
$0.11
>-$0.01(-3.94%)
Day’s Range― - ―
52-Week Range$0.04 - $0.14
Previous CloseN/A
Volume893.67K
Average Volume (3M)1.04M
Market Cap
$143.12M
Enterprise Value$221.56M
Total Cash (Recent Filing)$32.67M
Total Debt (Recent Filing)$57.65M
Price to Earnings (P/E)4.6
Beta0.58
Next Earnings
May 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding1,403,150,400
10 Day Avg. Volume1,190,854
30 Day Avg. Volume1,035,144
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.25
Enterprise Value/Market Cap1.55
Enterprise Value/Revenue1.46
Enterprise Value/Gross Profit2.55
Enterprise Value/Ebitda4.40
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)$118.37M
Bulls Say, Bears Say
Bulls Say
Balance-sheet Repair / Lower LeverageAuxly's deleveraging to roughly 0.32 debt-to-equity meaningfully lowers financial risk and interest burden, improving capital flexibility. This stronger capitalization supports supply agreements, operational stability, and reinvestment capacity, improving resilience over the next several quarters.
Improving Cash GenerationSustained positive operating and free cash flow, with a marked step-up in 2025, indicates the business can generate internal funding for working capital, capex, and debt reduction. Durable FCF enhances financial flexibility and reduces reliance on external financing during the medium term.
Consistent Revenue Scale-upSteady top-line growth over multiple years shows improving market penetration and scale in the Canadian adult-use market. Increasing revenue supports better absorption of fixed costs, enables margin expansion opportunities from higher-value derivatives, and underpins longer-term operating leverage.
Bears Say
Volatile Operating ProfitabilityThe reversion to operating losses in 2025 after a profitable 2024 highlights unstable core operating performance. Persistent or recurring negative operating margins would erode cash generation, limit reinvestment capacity, and raise execution risk for sustainable profitability over the coming months.
Limited Cash Cover For DebtAlthough cash flows improved, operating cash flow only modestly covers total debt, leaving a constrained liquidity cushion. That limited coverage reduces headroom for shocks or strategic initiatives and means further balance-sheet strengthening is needed to lower refinancing or covenant risks.
Earnings Quality And Durability ConcernsReported net income contrasts with negative operating and EBITDA margins, suggesting earnings may be influenced by non-operating items or timing effects. This uneven earnings quality complicates forecasting and implies caution when extrapolating current profits into future cash generation.
Auxly Cannabis Group News
CBWTF FAQ
What was Auxly Cannabis Group Inc’s price range in the past 12 months?
Auxly Cannabis Group Inc lowest stock price was $0.04 and its highest was $0.14 in the past 12 months.
What is Auxly Cannabis Group Inc’s market cap?
Auxly Cannabis Group Inc’s market cap is $143.12M.
When is Auxly Cannabis Group Inc’s upcoming earnings report date?
Auxly Cannabis Group Inc’s upcoming earnings report date is May 18, 2026 which is in 31 days.
How were Auxly Cannabis Group Inc’s earnings last quarter?
Auxly Cannabis Group Inc released its earnings results on Mar 26, 2026. The company reported <$0.001 earnings per share for the quarter, beating the consensus estimate of N/A by <$0.001.
Is Auxly Cannabis Group Inc overvalued?
According to Wall Street analysts Auxly Cannabis Group Inc’s price is currently Overvalued.
Does Auxly Cannabis Group Inc pay dividends?
Auxly Cannabis Group Inc does not currently pay dividends.
What is Auxly Cannabis Group Inc’s EPS estimate?
Auxly Cannabis Group Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Auxly Cannabis Group Inc have?
Auxly Cannabis Group Inc has 1,403,150,400 shares outstanding.
What happened to Auxly Cannabis Group Inc’s price movement after its last earnings report?
Auxly Cannabis Group Inc reported an EPS of <$0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -7.843%.
Which hedge fund is a major shareholder of Auxly Cannabis Group Inc?
Currently, no hedge funds are holding shares in CBWTF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Auxly Cannabis Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth C$75.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
182.85%
12-Months-Change
Fundamentals
Return on Equity
27.19%
Trailing 12-Months
Asset Growth
8.97%
Trailing 12-Months
Company Description
Auxly Cannabis Group Inc
Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. The company focuses on developing, manufacturing, and distributing cannabis products for wellness and recreational consumers. It offers cannabis products under various forms, including vape catridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy under the brands KOLAB PROJECT, Dosecann, BACK FORTY, and Foray. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Toronto, Canada.
CBWTF Earnings Call
Q4 2026
0:00 / 0:00
Technical Analysis
Canopy Growth
―
Organigram Global
―
Aurora Cannabis
―
Cronos Group
―
Trulieve Cannabis
―
Ownership Overview
5.56% Insiders
<0.01% Other Institutional Investors
94.44% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---